Finally, new blood testing provides real-time, dynamic information about a patient's clotting ability at the bedside.

Learn everything you need to know about VanEck Pharmaceutical ETF (PPH) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the right ...

“PPH requests appear to have been filed for less than 1% of U.S. applications. Why are applicants foregoing the program? While the program does not require payment of a fee per se, the author proposes ...

VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...

Pharmaceuticals underperformed the S&P 500 in 2023 but have been outperforming the broader market in 2024. The PPH fund offers exposure to pharmaceutical stocks and has outperformed its peers in terms ...

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on ...

A successful multifaceted intervention to reduce postpartum hemorrhage (PPH) and maternal mortality (MM) in Sub-Saharan Africa — and the related confirmation of a link between prenatal anemia and PPH ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We recently published 10 Most Popular Analyst Calls to Watch This Week. VanEck Pharmaceutical ETF (NASDAQ:PPH) is one of the trending stocks. Many analysts are picking healthcare stocks as indicators ...